From Lab to Boardroom at Sartorius

Episode 275

0:00-49:31

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with René, covering: How a lucky break brought him to Sartorius over 20 years ago, and what has changed and stayed the same over that time His journey from scientist to senior leader, and the evolution of biologics he has witnessed along the way The pace of innovation in bioprocessing, and how he thinks about speed, efficiency and flexibility Why innovation continues regardless of market cycles, through both boom and correction periods His perspective on the current biotech market reset and why it represents a healthy correction Despite building a €3.5bn powerhouse, how Sartorius has maintained a relentless focus on customers René Fáber, born in 1975, has been Head of Bioprocess Solutions Division and Member of the Executive Board of Sartorius AG since 2019. In the same year, he became a Member of the Board of Directors of Sartorius Stedim Biotech S.A.; in 2023 he was appointed as CEO of the company. René Fáber studied chemistry in Bratislava, Slovakia, and earned his Ph.D. in polymer chemistry from the Technical University of Munich in Germany. He joined Sartorius in 2002, where he initially worked as a scientist on membrane modification. As Vice President, he held various management positions in R&D, Marketing for Filtration and Fermentation Technologies, as well as in Key Account Management.

Publisher

Molecule to Market: Inside the outsourcing space

Link

molecule2market.podbean.com/e/from-lab-to-boardroom-at-sartorius/

Published

June 12, 2026

Duration

50 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Raman Sehgal

MT

Molecule to Market: Inside the outsourcing space

@moleculetomarketinsidetheout

#boardroom #sartorius #lifesciences

The Nile